GGrantIndex
← Leaderboards

Texas Heart Institute

Houston, TX

Compare ↔
$38,510,572
Total funding
26
Grants

Funding over time

peak $4.1M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$37,664,178 · 24
NASA$592,605 · 1
NSF$253,789 · 1

By mechanism

R01$22,136,356 · 10
UM1$4,821,058 · 1
RC1$2,000,000 · 2
U01$1,757,711 · 1
R33$1,628,403 · 2
P20$1,491,113 · 1

Investigators at Texas Heart Institute

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Ronald J Biediger$2,043,9584 gr2Xiao Li$651,9671 gr

Emerging Leaders

6–10 yrs in

1Camila Hochman-Mendez$1,652,2503 gr2Aydin Babakhani$1,196,7281 gr3Shaolie Samira Hossain$601,3842 gr4William Ettlinger Cohn$300,6901 gr

All-Time

Most funded here, all years

1O. H. Frazier$10,609,3215 gr2Darren G Woodside$3,775,0529 gr3Ronald J Biediger$2,043,9584 gr4Camila Hochman-Mendez$1,652,2503 gr5Aydin Babakhani$1,196,7281 gr6Emerson Carvalho Perin$1,000,0001 gr7Xiao Li$651,9671 gr8Shaolie Samira Hossain$601,3842 gr

Largest grants

Cardiovascular Cell Therapy Research Network$863,317
UM1 · FY2012 · HL
Effects of a Pulse Induced by a Constant-Flow Total Cardiac Replacement Device$826,447
R01 · FY2009 · HL
Effects of a Pulse Induced by a Constant-Flow Total Cardiac Replacement Device$806,818
R01 · FY2012 · HL
Effects of a Pulse Induced by a Constant-Flow Total Cardiac Replacement Device$793,479
R01 · FY2015 · HL
Effects of a Pulse Induced by a Constant-Flow Total Cardiac Replacement Device$792,506
R01 · FY2010 · HL
Cardiovascular Cell Therapy Research Network$791,909
UM1 · FY2014 · HL
Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility$787,884
R01 · FY2023 · HL
Effects of a Pulse Induced by a Constant-Flow Total Cardiac Replacement Device$786,666
R01 · FY2014 · HL
Cardiovascular Cell Therapy Research Network$776,390
UM1 · FY2013 · HL
Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility$752,493
R01 · FY2023 · HL
Combined Stem Cell and Assist Device Therapy for Heart Failure$749,253
P20 · FY2011 · HL
Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility$747,630
R01 · FY2020 · HL
Combined Stem Cell and Assist Device Therapy for Heart Failure$741,860
P20 · FY2010 · HL
A Novel Approach to Cardiac Replacement with Continuous Flow Pumps$711,684
R01 · FY2008 · HL
Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility$687,156
R01 · FY2022 · HL
Cardiovascular Cell Therapy Research Network$684,438
UM1 · FY2016 · HL
A Novel Approach to Cardiac Replacement with Continuous Flow Pumps$683,875
R01 · FY2009 · HL
Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility$683,158
R01 · FY2025 · HL
Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility$680,982
R01 · FY2024 · HL
Cardiovascular Cell Therapy Research Network$675,419
UM1 · FY2017 · HL